Soleno Therapeutics Inc (NASDAQ:SLNO) price on Friday, May 02, rose 0.28% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $75.23.
A look at the stock’s price movement, the close in the last trading session was $75.02, moving within a range at $74.74 and $76.16. The beta value (5-Year monthly) was -2.287. Turning to its 52-week performance, $76.56 and $36.93 were the 52-week high and 52-week low respectively. Overall, SLNO moved 2.12% over the past month.
Soleno Therapeutics Inc’s market cap currently stands at around $3.75 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SLNO is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend SLNO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SLNO’s current price about 7.18% and 27.19% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 66.19, while 7-day volatility ratio is 3.94% and 6.23% in the 30-day chart. Further, Soleno Therapeutics Inc (SLNO) has a beta value of -2.70, and an average true range (ATR) of 3.67. Analysts have given the company’s stock an average 52-week price target of $91.5, forecast between a low of $70 and high of $105. Looking at the price targets, the low is 6.95% off current price level while to achieve the yearly target high, price needs to move -39.57%. Nonetheless, investors will most likely welcome a -21.63% jump to $91.5 which is the analysts’ median price.
If we refocus on Soleno Therapeutics Inc (NASDAQ:SLNO), historical trading data shows that trading volumes averaged 0.84 over the past 10 days and 1.25 million over the past 3 months. The company’s latest data on shares outstanding shows there are 45.70 million shares.
The 20.63% of Soleno Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 81.05% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.01 million on 2025-04-15, giving us a short ratio of 2.11. The data shows that as of 2025-04-15 short interest in Soleno Therapeutics Inc (SLNO) stood at 1157.0 of shares outstanding, with shares short rising to 4.99 million registered in 2025-03-14. Current price change has pushed the stock 67.36% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SLNO stock continues to rise going into the next quarter.
